Relacorilant has 1 known drug interaction based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Paclitaxel (Aibumin-Bound). Patients taking Relacorilant should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Contraindicated
- 1
Contraindicated (1)
- Relacorilant + Paclitaxel (Aibumin-Bound)— Avoid coadministration of relacorilant plus nab-paclitaxel with strong CYP3A inducers. Both are CYP3A substrates; induce…